Literature DB >> 23643688

Assessing gait impairment after permanent middle cerebral artery occlusion in rats using an automated computer-aided control system.

Sidi Li1, Zhe Shi, Heng Zhang, Xinmin Liu, Shanguang Chen, Jian Jin, Yi Wang, William Jia, Haiqing Li.   

Abstract

Systematic gait analyses have been widely used in clinical settings as a reliable means of evaluating stroke severity and the efficacy of rehabilitation on people. However, the extent of gait changes post-stroke in experimental quadrupeds remains to be explored. To date, gait studies in cerebral ischemia have been limited to the mild ischemia-reperfusion model. However, studies on pathophysiology and therapy of experimental stroke suggest that permanent middle cerebral artery occlusion (pMCAO) is more similar to naturally occurring cerebral ischemia in humans. This is the first preclinical study to demonstrate that pMCAO rats can be used to assess long-term functional deficits related to gait by a computer-assisted method. Our gait analysis results demonstrate obvious gait deficits in the acute phase of the disease. During recovery, gait function gradually improved, but deficits were still detectable 42 days post-pMCAO. Objective and accurate photogrammetric parameters were used to illuminate laws of impairment and compensation in rats at different stages of cerebral ischemia in injured and uninjured limbs during walking. Compared to previous gait studies involving transient (t) MCAO rats, gait changes observed in pMCAO rats were more similar to changes following naturally occurring cerebral ischemia in humans. Importantly, the average body rotation and propulsion index, not previously used, are specific parameters for accurately assessing gait function during the acute phase of post-pMCAO. Furthermore, the gait test results revealed significant correlations between the final infarction volume and earlier behavioral outcomes. In conclusion, the gait analysis is a promising tool for assessing cerebral ischemia severity, and that it may provide a new means of investigating mechanisms of cerebral ischemia and evaluating potential therapies.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23643688     DOI: 10.1016/j.bbr.2013.04.044

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

2.  Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion.

Authors:  Kiril Tuntevski; Ryan Ellison; Sergiy Yakovenko
Journal:  J Vis Exp       Date:  2016-01-15       Impact factor: 1.355

3.  Gualou Guizhi Granule Protects Against Oxidative Injury by Activating Nrf2/ARE Pathway in Rats and PC12 Cells.

Authors:  Yuqin Zhang; Liming Fan; Huang Li; Xiaoying Wang; Wei Xu; Kedan Chu; Yu Lin
Journal:  Neurochem Res       Date:  2018-03-21       Impact factor: 3.996

4.  Simultaneous Determination of 11 Compounds in Gualou Guizhi Granule and Pharmacokinetics Study by UPLC-MS/MS.

Authors:  Chengtao Sun; Wen Xu; Yuqin Zhang; Lishuang Yu; Miao Ye; Kedan Chu; Wei Xu; Yu Lin
Journal:  J Anal Methods Chem       Date:  2017-07-20       Impact factor: 2.193

5.  The Impact of Ischemic Stroke on Gray and White Matter Injury Correlated With Motor and Cognitive Impairments in Permanent MCAO Rats: A Multimodal MRI-Based Study.

Authors:  Le Yang; Manzhong Li; Yu Zhan; Xuefeng Feng; Yun Lu; Mingcong Li; Yuming Zhuang; Jianfeng Lei; Hui Zhao
Journal:  Front Neurol       Date:  2022-03-02       Impact factor: 4.003

6.  Exercise on Striatal Dopamine Level and Anxiety-Like Behavior in Male Rats after 2-VO Cerebral Ischemia.

Authors:  Yongzhao Fan; Xiaoyang Kong; Kun Liu; Hao Wu
Journal:  Behav Neurol       Date:  2022-09-13       Impact factor: 3.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.